title: Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.
authors.forename: Sara
authors.initials: S
authors.lastname: García-Morán
authors.forename: Federico
authors.initials: F
authors.lastname: Sáez-Royuela
authors.forename: Juan-Carlos
authors.initials: JC
authors.lastname: Pérez-Alvarez
authors.forename: Elena
authors.initials: E
authors.lastname: Gento
authors.forename: José
authors.initials: J
authors.lastname: Téllez
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000009:adverse effects* / Q000627:therapeutic use; D008944:Mitral Valve Insufficiency / Q000139:chemically induced*; D009205:Myocarditis / Q000139:chemically induced*; D010493:Pericarditis / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine